Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
11/2007
11/14/2007CN100348587C Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient
11/13/2007WO2007134291A2 Products and processes for facilitating interaction between a merchant and a customer
11/13/2007US7294737 Reacting free hydroxyl-containing probucol or a derivative thereof (by which is meant a probucol compound with at least one substituent that is different from that on the parent probucol molecule but which maintains the two free hydroxyl groups) with a Grignard reagent or a lithium reagent
11/13/2007US7294686 Polymerization of aromatic monomers using derivatives of hematin
11/13/2007US7294646 Indole diterpene natural product and synthetic compound; Potassium channel blockers or a formulation thereof in the treatment of glaucoma and other conditions related to elevated intraocular pressure in the eye
11/13/2007US7294633 Oxazolo-and furopyrimidines and their use in medicaments against tumors
11/13/2007US7294632 E.g., 1'-[(2S)-2-Hydroxy-2-phenylethyl]-8'-pyridin-4-yl-3',4'-dihydrospiro[cyclopropane-1,2'-pyrimido[1,2-a]pyrimidin]-6'(1'H)-one; treating non-insulin dependent diabetes
11/13/2007US7294631 Substituted 8′-pyri(MI)dinyl-dihydrospiro-[cycloalkylamine]-pyrimido[1,2-a]pyrimidin-6-one derivatives
11/13/2007US7294625 Pyrazole compounds
11/13/2007US7294624 Barbituric acid derivatives as inhibitors of TNF-α converting enzyme (TACE) and/or matrix metalloproteinases
11/13/2007CA2248304C Surface modified carbonate materials
11/13/2007CA2235642C Processes for preparing sildenafil
11/08/2007WO2007127763A2 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/08/2007WO2007127138A1 Triazoloquinazolinone derivatives as inhibitors of checkpoint kinases
11/08/2007WO2007126745A2 Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
11/08/2007WO2007126128A1 Dihydropyrazolopyrimidinone derivative
11/08/2007WO2007126126A1 Novel aminopyridine derivative having aurora-a-selective inhibitory activity
11/08/2007WO2007126122A1 Dihydropyrazolopyrimidinone derivatives
11/08/2007WO2007125325A1 Pharmaceutical compounds
11/08/2007WO2007125321A2 Purine and deazapurine derivatives as pharmaceutical compounds
11/08/2007WO2007125315A2 Pharmaceutical compounds
11/08/2007WO2007124543A1 Profluorescent nitroxide compounds
11/08/2007WO2007087395A3 UNSATURATED mTOR INHIBITORS
11/08/2007WO2006106423A8 Amino sulfonyl derivatives as inhibitors of human 11-.beta.-hydrosysteroid dehydrogenase
11/08/2007US20070260087 Process of Preparing Esters and Ethers of Probucol and Derivatives Thereof
11/08/2007US20070260062 Heterocyclical Chromophore Architectures with Novel Electronic Acceptor Systems
11/08/2007US20070260057 Methods for the preparation of pyrazole-containing compounds
11/08/2007US20070259944 Amides such as 5-(3-Nitrophenyl)-1,3-dihydro-indol-2-one, used as antiprogesterones, contraceptives, for hormone replacement therapy during menopause and as anticarcinogenic agents
11/08/2007US20070259902 Farnesyl transferase inhibiting 1,2-annelated quinoline enantiomer
11/08/2007US20070259899 2-(4-Morpholin-4-yl-phenylamino)-6-(2-trifluoromethyl-phenyl)-pyrido[2,3-d]pyrimidine-7-carboxylic acid (pyrrolidin-2-ylmethyl)-amide, for example; anticarcinogenic agents; improved activity, tolerability, selectivity or stability
11/08/2007US20070259895 MGluR5 modulators VI
11/08/2007US20070259893 Pyrazolopyrimidines
11/08/2007US20070259882 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
11/08/2007US20070259860 MGluR5 modulators V
11/08/2007US20070259858 Novel bis-pyrrolo[2,1-c][1,4]benzodiazepine-anthraquinone conjugates and a process for the preparation thereof
11/08/2007US20070259852 Such as 2-(2-hydroxycarbamoylmethyl-3-oxo-2,3-dihydro-benzo[1,4]thiazin-4-yl)-propionamide; peptidyl deformylase (PDF) inhibitors; for treatment of bacterial infections
11/08/2007US20070259851 4-(2-Oxo-1,4-dihydro-2H-quinazolin-3-yl)-piperidine-1-carboxylic acid (9-benzyl-8-oxo-3,6,7,8,9,10-hexahydro-2,3,9-triaza-(R)-cyclohepta[e]inden-7-yl)-amide; calcitonin gene-related peptide receptor antagonist; analgesic, antiinflammatory agent; migraine, neurogenic vasodilation, menopause, asthma
11/08/2007US20070259850 [9-(2,2-Dimethyl-propyl)-8-oxo-3,6,7,8,9,10-hexahydro-2,3,9-triaza-(S)-cyclohepta[e]inden-7-yl]-acetic acid methyl ester; calcitonin gene-related peptide receptor antagonist; analgesic, antiinflammatory agent; migraine, neurogenic vasodilation, circulatory shock, menopause, asthma
11/08/2007US20070259281 Hydroxygallium phthalocyanines
11/08/2007US20070258887 antemortem method of diagnosing Alzheimer's disease and quantitating extent or progression of amyloid deposits by in vivo imaging of brain
11/08/2007CA2665818A1 Therapeutic compounds
11/08/2007CA2650572A1 Novel aminopyridine derivatives having aurora a selective inhibitory action
11/08/2007CA2650119A1 Dihydropyrazolopyrimidinone derivatives
11/08/2007CA2649811A1 Triazoloquinazolinone derivatives as inhibitors of checkpoint kinases
11/08/2007CA2648019A1 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/07/2007EP1852434A1 Bicyclic carbamoylpyridone derivative having hiv integrase inhibiting activity
11/07/2007EP1852422A2 Nitrosated and nitorsylated alpha-andrenergic receptor antagonist compounds, compositions and their uses
11/07/2007EP1851225A1 Pyrazolo-pyrimidine derivatives as mglur2 antagonists
11/07/2007EP1851219A1 Fused heterocyclic compounds useful as inhibitors of histone deacetylase
11/07/2007EP1850853A2 Pharmacokinetically improved compounds
11/07/2007EP1850849A2 Method of preferentially inducing the biosynthesis of interferon
11/07/2007EP1689749B1 Process for preparing substituted 5-amino-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines
11/07/2007EP1543008B1 Imidazopyrazines as cyclin dependent kinase inhibitors
11/07/2007EP1361225B1 Compounds substituted with bicyclic amino groups
11/07/2007CN101068815A Lactam compounds useful as protein kinase inhibitors
11/07/2007CN101068795A Heterocyclical chromophore architectures with novel electronic acceptor systems
11/07/2007CN101068772A N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
11/07/2007CN101066945A Process of synthesizing 3-substituted lactan compound
11/07/2007CN100346784C Pharmaceutical formulations of antineoplastic agents,in particular temozolomide, processes of making and using the same
11/06/2007US7291738 A (2-methyl-3-pyridinyl)oxy)-3-pyridinyl)urea derivatives for treatment of a disease or disorder of the central nervous system, medical diagnosis
11/06/2007US7291732 Isomeric fused pyrrolocarbazoles and isoindolones
11/06/2007US7291731 7-(3-Pyridyl)-1,7-diazaspiro-[4,4]nonane and its salts and proline amides; capable of affecting nicotinic cholinergic receptors, e.g., as modulators of specific nicotinic receptor subtypes; neuroprotective agents
11/06/2007US7291727 Can be aligned to form an ordered architecture that can facilitate charge transport in the direction along the columns, processed to form a large area single crystalline thin film, and respond to external light irradiation; high-efficiency photovoltaic materials and organic light emitting devices
11/06/2007US7291618 (3,3-Difluoropyrrolidin-1-yl)-((2S,4S)-4-(4-(pyrimidin-2-yl) piperazin-1-yl)pyrrolidin-2-yl)methanone, usedin treating diabetic complications including diabetic neuropathy, diabetic nephropathy, diabetic microangiopathy, and the like.
11/06/2007CA2427576C Benzodiazepine derivatives as gaba a receptor modulators
11/06/2007CA2202058C Cyclic hexapeptides having antibiotic activity
11/01/2007WO2007124337A1 Biphenyl amide lactam derivatives as inhibitors of 11- beta-hydroxysteroid dehydrogenase 1
11/01/2007WO2007124332A1 PROCESS FOR THE PREPARATION OF [(1R), 2S]-2-AMINOPROPIONIC ACID 2-[4-(4-FLUORO-2-METHYL-1H-INDOL-5-YLOXY)-5-METHYLPYRROLO[2,1-f][1,2,4]TRIAZIN-6-YLOXY]-1-METHYLETHYL ESTER
11/01/2007WO2007123269A1 Azolecarboxamide derivative
11/01/2007WO2007122847A1 Reagent for organic synthesis and method of organic synthesis reaction with the reagent
11/01/2007WO2007122219A1 3- (aminomethyliden) 2-indolinone derivatives and their use as cell proliferation inhibitors
11/01/2007WO2007092416A3 Melanin concentrating hormone receptor-1 antagonists
11/01/2007WO2007050673A3 Cyclin dependent kinase inhibitors
11/01/2007WO2006103399A8 Hiv integrase inhibitors
11/01/2007WO2005000402A3 Anti-adhesion composites and methods os use thereof
11/01/2007US20070254935 Pyrazole and imidazole compounds and uses thereof
11/01/2007US20070254898 Thienopyrimidine and Thienopyridine Derivatives Substituted with Cyclic Amino Group
11/01/2007US20070254892 Dihydropyrazolopyrimidinone derivatives
11/01/2007US20070254883 3-cyclobutyl-1-[(4-phenoxyphenyl)ethynyl]imidazo[1,5-a]pyrazin-8-amine, N-{3-[(8-amino-3-cyclobutylimidazo[1,5-a]pyrazin-1-yl)ethynyl]phenyl}-4-chlorobenzamide; inhibitors of mammalian Target Of Rapamycin (mTOR) kinase; cancer
11/01/2007US20070254877 Indole Derivative and Use for Treatment of Cancer
11/01/2007US20070254867 Heterocyclic Kinase Inhibitors
11/01/2007US20070254865 Aminocyclohexanes as Dipeptidyl Peptidase-Iv Inhibitors for the Treatment or Prevention of Diabetes
11/01/2007US20070254046 such as 4-Aminomethyl-N-[4-(5-biphenyl-4-yl-pyrazolo[1,5-c]pyrimidin-7-ylamino)-phenyl]-benzamide, useful in the therapy of (hyper)proliferative diseases and/or disorders responsive to induction of apoptosis
11/01/2007CA2650059A1 Process for the preparation of [(1r), 2s]-2-aminopropionic acid 2-[4-(4-fluoro-2-methyl-1h-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-1-methylethyl ester
11/01/2007CA2649043A1 Azolecarboxamide derivative
11/01/2007CA2646638A1 3- (aminomethyliden) 2-indolinone derivatives and their use as cell proliferation inhibitors
10/2007
10/31/2007EP1849786A1 Method for producing nucleoside derivative
10/31/2007EP1849782A1 Quinolinone derivatives as tyrosine kinase inhibitors
10/31/2007EP1849469A1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
10/31/2007EP1848778A2 De novo synthesis of bacteriochlorins
10/31/2007EP1848749A2 Contact drug delivery system
10/31/2007EP1848719A1 [1h-pyrazolo[3,4-d]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-threonine kinase modulators (p70s6k, atk1 and atk2) for the treatment of immunological, inflammatory and proliferative diseases
10/31/2007EP1848694A1 Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1
10/31/2007EP1848506A2 Pyrimidine-fused diazepine derivatives and indole-fused pteridines
10/31/2007EP1848437A2 Methods of making pharmacokinetically improved compounds comprising functional residues or groups and pharmaceutical compositions comprising said compounds
10/31/2007EP1503760A4 Camptothecin derivatives and polymeric conjugates thereof
10/31/2007EP1496896A4 Inhibitors of akt activity
10/31/2007EP1289993B1 Caspase inhibitors and uses thereof
10/31/2007EP1218337B1 Synthesis of 3,5,7|-1h-imidazo 1,5-a|imidazol-2(3h)-one compounds
10/31/2007CN101065383A 7-aminomethyl-1,2,4-triazolo[1,5-a]pyrimidine compounds and their use for controlling pathogenic fungi
1 ... 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 ... 573